Latest Sirtex Stories
SYDNEY, March 17, 2015 /PRNewswire/ -- - In the first-line treatment of non-resectable metastatic colorectal cancer: - SIRFLOX study
PARIS, March 4, 2015 /PRNewswire/ -- Launched by the Assistance Publique - Hopitaux de Paris in December 2011,'SARAH' - the French national collaborative randomized controlled
SYDNEY, January 29, 2015 /PRNewswire/ -- Combined data from more than 1,000 patients being collected to assess overall survival (OS) benefit of adding first-line
Growing Interest in these Minimally Invasive Treatments Will Nonetheless Spur Strong Market Growth Overall, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.
BONN, Germany, September 29, 2014 /PRNewswire/ -- Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of metastatic colorectal
In the news release, The Asia Pacific Transcatheter Embolization and Occlusion Device Market Will Be Driven By the Adoption of Flow-Diverting Devices and Radioembolization Spheres, issued 08-Jul-2014
Australia Has the Strongest Presence of These Innovative Products, But Competitors Are Increasingly Focusing on China, According to Findings from Decision Resources Group BURLINGTON, Mass.,
PRINCETON, N.J., March 24, 2014 /PRNewswire/ -- Sirtex Medical Limited (ASX: SRX) and Guerbet S.A.
Transparency Market Research Report adds "Global Microspheres Market - Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its database.
- Growing in low tufty patches.